FDA.reportPublic FDA data

methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]

RxCUI
1100391
RxNorm name
methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]
Display name
HYBRISIL (Topical)
Full name
methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]
Term type
SBD
Status
Active
Strength
1%
Dose form
Gel
Route
Topical
Updated
2026-10-15 15:42:33

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062011
Active start
062011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methylprednisolone acetate0.01 MG / 1 MGmethylprednisolonemethylprednisolone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Gel346286

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methylprednisolone6902

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRHybriSil 1 % Topical Gel1NAMES
RxNorm Namemethylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_IDf8432414-d8a6-4597-a226-61fd09a80e0c1CODES
RxCUI11003911CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
55379040530rxnav_ndcsyes
55379040531rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f8432414-d8a6-4597-a226-61fd09a80e0cHybriSil 1 % Topical Gel [PSN] · methylprednisolone acetate 0.01 MG/MG Topical Gel [HybriSil] [SBD] · HybriSil 0.01 MG/MG Topical Gel [SY] · HybriSil 1 % Topical Gel [SY]4220110422

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f8432414-d8a6-4597-a226-61fd09a80e0cBioZone Laboratories, Inc.20110422

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AACorticosteroids, combinations for treatment of acneATC1-4methylprednisolone
ATCD07AACorticosteroids, weak (group I)ATC1-4methylprednisolone
ATCH02ABGlucocorticoidsATC1-4methylprednisolone
FDASPLN0000175576CorticosteroidEPChas_epcmethylprednisolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTD008775MethylprednisoloneCHEMhas_ingredientmethylprednisolone
MEDRTD000077555Methylprednisolone AcetateCHEMhas_ingredientmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone acetate
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone acetate
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone acetate
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone acetate
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone acetate
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone acetate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone acetate
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone acetate
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone acetate
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD007223InfantDISEASEci_withmethylprednisolone
MEDRTD007223InfantDISEASEci_withmethylprednisolone acetate
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone acetate
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone
MEDRTD009181MycosesDISEASEci_withmethylprednisolone acetate
MEDRTD009181MycosesDISEASEci_withmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone acetate
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone acetate
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone acetate
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone acetate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.01 MG/MG (expressed as methylprednisolone acetate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymHybriSil 1 % Topical Gel
NAMESTallman SynonymmethylPREDNISolone acetate 0.01 MG/MG Topical Gel [HybriSil]
SOURCESSourceMetathesaurus FDA Structured Product Labels